Profusa, Inc. (PFSA)
NASDAQ: PFSA · Real-Time Price · USD
0.5600
+0.0700 (14.29%)
At close: Aug 13, 2025, 4:00 PM
0.5509
-0.0091 (-1.63%)
After-hours: Aug 13, 2025, 7:03 PM EDT
Company Description
Profusa, Inc. develops bioengineered sensors that are designed to become one with the body to detect and continuously transmit clinical -grade data for personal and medical use.
The company was incorporated in 2009 and is based in Emeryville, California.
Profusa, Inc.
| Country | United States |
| Founded | 2009 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 15 |
| CEO | Ben Hwang |
Contact Details
Address: 5959 Horton Street, Suite 450 EmeryVille, California 94608 United States | |
| Phone | 415 655 9861 |
| Website | profusa.com |
Stock Details
| Ticker Symbol | PFSA |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001859807 |
Key Executives
| Name | Position |
|---|---|
| Ben Chung-Bin Hwang Ph.D. | Chief Executive Officer and Chairman |
| William McMillan | Co-founder, Chief Scientific Officer and Head of Research |
| Sean Givens | Head of Government Business |
| Phil Constantinou | Head of Software and Data Science |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 11, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Aug 11, 2025 | PRE 14A | Other preliminary proxy statements |
| Aug 7, 2025 | 8-K | Current Report |
| Jul 28, 2025 | 8-K | Current Report |
| Jul 24, 2025 | SCHEDULE 13G | Filing |
| Jul 18, 2025 | 8-K | Current Report |
| Jul 15, 2025 | DEF 14C | Filing |
| Jul 11, 2025 | CERT | Certification by an exchange approving securities for listing |
| Jul 11, 2025 | 8-A12B | Registration of securities |
| Jul 3, 2025 | 8-K | Current Report |